BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/27/2022 10:06:45 AM | Browse: 362 | Download: 1567
 |
Received |
|
2022-05-31 04:44 |
 |
Peer-Review Started |
|
2022-05-18 18:48 |
 |
First Decision by Editorial Office Director |
|
2022-08-01 18:33 |
 |
Return for Revision |
|
2022-08-01 18:33 |
 |
Revised |
|
2022-10-02 15:41 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2022-10-26 03:26 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2022-10-26 19:11 |
 |
Articles in Press |
|
2022-10-26 19:11 |
 |
Edit the Manuscript by Language Editor |
|
2022-11-03 22:43 |
 |
Typeset the Manuscript |
|
2022-12-21 03:29 |
 |
Publish the Manuscript Online |
|
2022-12-27 10:06 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Neurosciences |
| Manuscript Type |
Basic Study |
| Article Title |
Bladder-colon chronic cross-sensitization involves neuro-glial pathways in male mice
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Karim Atmani, Fabien Wuestenberghs, Maximilien Baron, Illona Bouleté, Charlène Guérin, Wafa Bahlouli, David Vaudry, Jean Claude do Rego, Jean-Nicolas Cornu, Anne-Marie Leroi, Moïse Coëffier, Mathieu Meleine and Guillaume Gourcerol |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Guillaume Gourcerol, MD, PhD, Chief Doctor, Professor, Department of Physiology, CHU Rouen, Université de Rouen Normandie, 1 Rue de Germont, Rouen 76031, France. guillaume.gourcerol@chu-rouen.fr |
| Key Words |
Cross-organ sensitization; MAPK-p38; Microglia; NK1 receptor; Pain; Visceral hypersensitivity |
| Core Tip |
A model of chronic cross-organ visceral sensitization in mice was developed using ultrasound-guided intravesical injections of acetic acid. Visceral hypersensitivity to colorectal distension was observed as early as one hour post-injection and lasted up to seven days. Visceral hypersensitivity was associated with an increased expression of c-Fos protein in the spinal cord. NK1 receptor and MAPK-p38 levels were upregulated in the spinal cord seven days post-injection. Colorectal sensitization was prevented by intrathecal or intracerebroventricular (ICV) injections of minocycline, a microglia inhibitor, by ICV injection of CP-99994, a NK1 antagonist, and by ICV injection of SB203580, a MAPK-p38 inhibitor. |
| Publish Date |
2022-12-27 10:06 |
| Citation |
Atmani K, Wuestenberghs F, Baron M, Bouleté I, Guérin C, Bahlouli W, Vaudry D, do Rego JC, Cornu JN, Leroi AM, Coëffier M, Meleine M, Gourcerol G. Bladder-colon chronic cross-sensitization involves neuro-glial pathways in male mice. World J Gastroenterol 2022; 28(48): 6935-6949 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i48/6935.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i48.6935 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.